OFOST 16.7mcg / ml injection / infusion solution medication leaflet

H01BB02 oxytocin • Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Oxytocin and analogues

Oxytocin is a hormone used in obstetrics to induce labor, stimulate uterine contractions, or control postpartum hemorrhage. It works by stimulating oxytocin receptors in the uterus, causing muscle contractions.

The medication is administered intravenously or intramuscularly, as directed by a doctor, usually in doses adjusted based on the patient's response. It is important for administration to be performed under strict medical supervision.

Patients should be aware of potential side effects, such as nausea, vomiting, or uterine hypertonia. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and uterine hypertonia. In rare cases, severe reactions such as uterine rupture or allergic reactions may occur. Patients should be informed of these risks before use.

General data about OFOST 16.7mcg / ml

Substance: oxytocin

Date of last drug list: 01-05-2025

Commercial code: W67079002

Concentration: 16.7mcg / ml

Pharmaceutical form: injection / infusion solution

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: AS GRINDEKS - LETONIA

Holder: AS GRINDEKS - LETONIA

Number: 13440/2020/02

Shelf life: 2 years

Concentrations available for oxytocin

16.7mcg/ml, 1UI/ml, 5UI/ml, 8.3mcg/ml

Other substances similar to oxytocin